Caligan Partners LP

Q1 2025 13F Holdings

  • Location
    new york, NY
  • Num holdings

    16

  • Value ($000)

    $479,229

  • Date Filed
    05/15/2025
  • Form type
    13F-HR
  • CIK
    0001727492
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
LQDA
LQDA

LIQUIDIA CORPORATION

COM NEW
53635D202
$119.75M
25 %

8,118,592

VRNA
VRNA

VERONA PHARMA PLC

SPONSORED ADS
925050106
$91.23M
19 %

1,436,878

EX9
EX9

EXELIXIS INC

COM
30161Q104
$56.33M
12 %

1,525,730

MLYS
MLYS

MINERALYS THERAPEUTICS INC

COM
603170101
$34.14M
7 %

2,149,667

EOLS
EOLS

EVOLUS INC

COM
30052C107
$32.86M
7 %

2,731,154

SAGE
SAGE

SAGE THERAPEUTICS INC

COM
78667J108
$24.27M
5 %

3,052,538

BCRX
BCRX

BIOCRYST PHARMACEUTICALS INC

COM
09058V103
$23.31M
5 %

3,107,669

ANIK
ANIK

ANIKA THERAPEUTICS INC

COM
035255108
$21.57M
5 %

1,435,130

AGIO
AGIO

AGIOS PHARMACEUTICALS INC

COM
00847X104
$20.55M
4 %

701,280

RVMD
RVMD

REVOLUTION MEDICINES INC

COM
76155X100
$16.44M
3 %

465,000

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 16